CHICAGO EQUITY PARTNERS LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$639,000
-56.4%
26,940
-49.5%
0.04%
-47.1%
Q3 2019$1,466,000
-48.1%
53,345
-37.5%
0.07%
-44.4%
Q2 2019$2,823,000
-6.2%
85,320
-0.7%
0.13%
+8.6%
Q1 2019$3,011,000
+5.5%
85,9350.0%0.12%
+0.9%
Q4 2018$2,855,000
-36.5%
85,935
-3.8%
0.12%
-12.9%
Q3 2018$4,497,000
-13.0%
89,305
+3.4%
0.13%
-16.5%
Q2 2018$5,167,00086,3400.16%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders